CollPlant Biotechnologies Ltd

Other Health CareRegenerative MedicineBioprintingBiotech

📍 Rehovot, Israel• Founded 2004

StreetZero Signal 67

Be the first to signal interest

About CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. The company's products are based on its rhCollagen (recombinant human collagen) produced with its proprietary plant-based genetic engineering technology. These products address indications for tissue repair, medical aesthetics, and 3D bioprinting of tissues and organs. The company was founded in 2004 and is headquartered in Rehovot, Israel.

LATEST FUNDINGPrivate Placement

$9.2M

Announced 2026-10-22

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for CollPlant Biotechnologies Ltd.

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED2004

HQRehovot, Israel

Industry

Other Health Care

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Company uses proprietary plant-based technology to produce recombinant human Type I collagen identical to human collagen.
Focuses on 3D bioprinting of tissues and organs plus medical aesthetics products.
Completed a $9.25 million private placement with no investors disclosed.
Publicly traded on Nasdaq under ticker CLGN.
Headquartered in Rehovot, Israel and founded in 2004.